The aim of this study was to evaluate the prevalence of some virulence genes among 202 Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients (n=42) and non-CF in-patients (n=160) 
INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen that is a common cause of hospital-acquired infections, particularly infecting patients with predisposing factors, such as burn victim, immunocompromised hosts, or those with metabolic disorders. In cystic fibrosis (CF) patients, P. aeruginosa is believed to be a major contributory factor to chronic lung infections, which could form biofilm and adhere to human mucin in the lower respiratory tract (23) . The organism can Virulence genes in P. aeruginosa only be eradicated in the early stage of colonization, while reduction of bacterial density is desirable during chronic colonization or exacerbations (3). It is not surprising that P. aeruginosa infections are associated with significant morbidity and mortality due to the organism's capacity to adapt easily to changes in the environment, to rapidly develop resistance to antibiotics, and to produce a variety of virulence factors.
P. aeruginosa possesses an "arsenal" of cell-associated and extracellular virulence factors. Many extracellular virulence factors have been shown to be controlled by a complex regulatory circuit involving cell-to-cell signaling (quorum sensing) systems that allow the bacteria to produce these factors in a coordinated, cell-density-dependent manner (22) .
The aim of this study was to examine the prevalence of 
MATERIALS AND METHODS

Bacterial isolates and patients
A total of 202 clinical isolates of P. aeruginosa (including 160 nosocomial and 42 CF) was used in the present study. The nosocomial isolates were cultured during 2001-2007 from hospitalized non-CF patients (n=160) of different types of ward in six large hospitals in Sofia, Bulgaria. They were obtained from urine (n=62), tracheal aspirates (n=22), bronchial lavage (n=12), sputum (n=9), pleural fluid (n=2), surgical wounds or abscesses (n=26), blood (n=8), nose (n=8), throat (n=8), and bile (n=3). The CF P. aeruginosa isolates were recovered from sputa of 42 patients (25 females and 17 males) aged 6-27 years during the period 2005-2008. Bacterial identification was performed using a BBL Enteric/Nonfermenter ID system (Becton Dickinson).
CF exacerbation diagnostic criteria
An acute exacerbation was defined, as per the 1994 Cystic Fibrosis Foundation (CFF) Microbiology Consensus Conference (4), as the presence of at least 3 of 11 new clinical findings, including increased cough, increased sputum production, fever, weight loss, school or work absenteeism, increased work of breathing, decreased exercise tolerance, or a deterioration in the chest exam, chest radiograph, forced expiratory volume in 1 s (FEV 1 ), or hemoglobin saturation.
Definition of multidrug-resistant (MDR) isolates
Multidrug-resistant (MDR) P. aeruginosa isolates were defined as resistant to at least three of the following antibiotics: ceftazidime, imipenem, gentamicin and ciprofloxacin (14) , using the conventional serial agar dilution method. The minimal inhibitory concentrations were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) 2007 guide-line (5) .
Polymerase chain reaction (PCR) amplification of virulence genes
The prevalence of virulence genes, encoding GDP mannose 6-dehydrogenase (alginate) (algD), type IV fimbrial biogenesis protein PilB (pilB), neuraminidase (nan1), elastase LasB (lasB), haemolytic phospholipase C precursor (plcH), exoenzyme S (exoS) and exoenzyme U (exoU), was determined by PCR. The virulence genes were amplified with specific primers (Alpha DNA) listed in 
Statistical analysis
The distribution of virulence genes with respect to isolate origin was compared using the chi-square test. A P value below 0.05 was considered to be statistically significant.
RESULTS
Prevalence of virulence genes among all studied P. aeruginosa isolates
The frequencies of occurrence of virulence genes in all studied strains (n=202) were as follows: algD -91.1%, pilB - (iii) The detection of pilB and plcH among CF isolates was significantly lower than that in non-CF nosocomial strains (P<0.01 and P<0.001, respectively).
Prevalence of virulence genes with respect to the infection localization in non-CF patients
The distribution of virulence genes encoding adhesins (alginate, type IV pili), neuraminidase, invasins (elastase LasB, haemolytic phospholipase C) and type III effector proteins (ExoS, ExoU) varied in respect to the infection localization in non-CF patients ( 
Prevalence of virulence genes among MDR and non-MDR
P. aeruginosa isolates from non-CF patients
Of the 160 nosocomial non-CF P. aeruginosa isolates, 92
were MDR. Three of the genes (pilB, nan1 and exoU) The proportion of MDR nosocomial P. aeruginosa isolates containing a large number of virulence genes ( 5) (38.1%) was higher than the proportion of non-MDR isolates with a large number of virulence genes (17.6%) -P<0.01 (Table 3) . 
DISCUSSION
The established prevalence of some of the genes (algD, lasB and plcH) among all studied P. aeruginosa isolates (n=202) was similar to their widespread dissemination (100%) It was not surprising that the detection of nan1 among the investigated CF P. aeruginosa was significantly higher than that in non-CF isolates. Three decades ago, neuraminidase production by a CF P. aeruginosa isolate was described and suggested to contribute to lung infection (16) . The spread of nan1 in CF P. aeruginosa isolates increases when the clinical state of patients worsens, suggesting the possible role of neuraminidase in CF pulmonary disease evolution (15, 21) .
The prevalence of nan1 among our CF isolates was significantly lower (P<0.02) than that in French CF P. There were no additional new changes on X-ray findings. The spirometry showed steady levels of forced vital capacity and FEV 1 , slightly decreasing with the age. The sputum cytology manifested steady levels of polynuclear cells and the rate of metaplasia was not increasing significantly with check-ups.
In the present study, exoS gene was found more rarely in CF isolates than in the other clinical isolates (52.4% vs.
65.0%), which contrasted with the reported higher secretion of ExoS by P. aeruginosa strains from sputa of CF individuals (6, 8, 15) . According to the data published by Lanotte et al. (15) , the prevalence of exoS among CF P. aeruginosa isolates was significantly higher than that in non-CF isolates (93.8% vs. The frequency of pilB among the studied CF P.
aeruginosa was low (9.5%) which suggested the role of nonpilus adhesins (such as alginate) in this group of isolates.
Recently, it was ascertained an absolute absence of pilB among CF P. aeruginosa strains from Ireland (9).
As it was described above, the distribution of virulence genes varied in respect to the site of infection among non-CF fluoroquinolones, and aminoglycosides (gentamicin) (10).
In conclusion, the present study established a higher frequency of spread of nan1 among CF P. aeruginosa isolates compared with that in non-CF isolates. This prevalence was moderate and correlated with the lower proportion of patients with lung exacerbations. The molecular-genetic detection of the nan1 gene may be used as an indirect measure of CF pulmonary disease evolution. The distribution of virulence genes varied in respect to the site of infections among non-CF hospitalized patients. For the first time, it was found that the frequencies of pilB, exoU and nan1 were significantly higher in MDR strains than those in non-MDR P. aeruginosa strains.
Moreover, the part of MDR isolates containing a large number of virulence factors ( 5) was bigger than the respective partition of non-MDR P. aeruginosa. The exact reasons for the frequent presence of virulence-related genes in MDR isolates are still unknown therefore a further work is necessary.
Simultaneous determination of virulence factors and antimicrobial resistance is a contemporary approach for examination of the microbiological aspects of infections caused by P. aeruginosa.
